Which pricing strategy was specifically created through the Orphan Drug Act to incentivize pharmaceutical companies to develop medications for rare diseases affecting fewer than 200,000 patients in the US?

The pharmaceutical industry faces unique challenges in pricing medications, especially for rare diseases. This trivia question focuses on a specific pricing strategy that revolutionized treatment development for rare conditions. Understanding these specialized pricing approaches reveals how pharmaceutical companies balance innovation costs with market sustainability while addressing critical patient needs. Test your knowledge about this important aspect of medical product development!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Premium pricing with market exclusivity
Value-based rebate programs
Tiered formulary placement
Reference-based international pricing